RECOMMENDATION reiterate WANG LABS ltWANB Analyst Thomas McCrann Merrill Lynch reiterate buy recommendation Wang Laboratories Inc note successful cost cutting campaign reduce earning loss expect quarter end March Wang actively trade stock American Stock Exchange rise 34 1658 McCrann Wang bit ahead expect cost reduction result odd increase loss quarter expect McCrann expect Wang report break earning share small loss share quarter year however company report loss 50 ct share compare earning 35 ct share year ago